Errata (DOI:10.1016/S1474-4422(09)70272-8);Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

The Lancet Neurology

Volumn 9, Issue 2, 2010, Pages 177-189

  Bushby, Katharine ^a   Finkel, Richard ^b   Birnkrant, David J ^c   Case, Laura E ^d   Clemens, Paula R ^e   Cripe, Linda ^f   Kaul, Ajay ^f   Kinnett, Kathi ^f   McDonald, Craig ^g   Pandya, Shree ^h   Poysky, James ⁱ   Shapiro, Frederic ^j   Tomezsko, Jean ^b   Constantin, Carolyn ^k  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISACODYL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENEMA; GLUCOCORTICOID; HISTAMINE H2 RECEPTOR ANTAGONIST; INFLUENZA VACCINE; LACTULOSE; LAXATIVE; MACROGOL; MAGNESIUM HYDROXIDE; MULTIVITAMIN; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SUCRALFATE; UNINDEXED DRUG; VITAMIN D;

AEROBIC EXERCISE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACKACHE; BLEEDING; BONE HEALTH; BREATHING EXERCISE; CARDIOMYOPATHY; CAST APPLICATION; COMPRESSION GARMENT; CONSTIPATION; COUGHING; DEEP VEIN THROMBOSIS; DEFIBRILLATOR; DUCHENNE MUSCULAR DYSTROPHY; DYSPHAGIA; ELECTROCARDIOGRAM; EMERGENCY WARD; EXERCISE; FECES IMPACTION; FLUID INTAKE; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; GASTROSTOMY; GENERAL SURGERY; HEALTH; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HUMAN; HYPOVENTILATION; HYPOXEMIA; IMMUNIZATION; INFECTION; JOINT CONTRACTURE; LANGUAGE; LEG FRACTURE; MOBILIZATION; MUSCLE STRETCHING; NUTRITION; ORTHOPEDICS; ORTHOSIS; OSTEOPOROSIS; OSTEOSYNTHESIS; OXYGEN THERAPY; PAIN; PATIENT POSITIONING; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANGE OF MOTION; REHABILITATION CARE; RESPIRATORY CARE; RESPIRATORY FAILURE; REVIEW; SCOLIOSIS; SENNA; SLEEP DISORDERED BREATHING; SPEECH; SPEECH DISORDER; SPEECH THERAPY; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; SPLINTING; SURGICAL TECHNIQUE; SWALLOWING; SWIMMING; TENDON TRANSFER; THROMBOEMBOLISM; TRACHEOSTOMY; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WALKING AID;

EID: 76549130473     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70003-X     Document Type: Erratum

References (157)

1. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol (2009) 10.1016/S1474-4422(09)70271-6 published online Nov 30.
2. Fitch K., Bernstein S.J., Aguilar M.S., et al. The RAND/UCLA appropriateness method user's manual (2001), RAND Corporation, Santa Monica, CA
3. Brooke M.H., Fenichel G.M., Griggs R.C., et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 39 (1989) 475-481
4. Johnson E.W., and Walter J. Zeiter Lecture: pathokinesiology of Duchenne muscular dystrophy: implications for management. Arch Phys Med Rehabil 58 (1977) 4-7
5. Sutherland D.H., Olshen R., Cooper L., et al. The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol 23 (1981) 3-22
6. Archibald K.C., and Vignos Jr. P.J. A study of contractures in muscular dystrophy. Arch Phys Med Rehabil 40 (1959) 150-157
7. Johnson E.R., Fowler Jr. W.M., and Lieberman J.S. Contractures in neuromuscular disease. Arch Phys Med Rehabil 73 (1992) 807-810
8. Hsu J.D., and Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res 288 (1993) 122-125
9. McDonald C.M., Abresch R.T., Carter G.T., et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 74 suppl (1995) S70-S92
10. Dubowitz V. Progressive muscular dystrophy: prevention of deformities. Clin Pediatr (Phila) 12 (1964) 323-328
11. Dubowitz V. Prevention of deformities. Isr J Med Sci 13 (1977) 183-188
12. Fowler Jr. W.M. Rehabilitation management of muscular dystrophy and related disorders: II. Comprehensive care. Arch Phys Med Rehabil 63 (1982) 322-328
13. Vignos Jr. P.J. Physical models of rehabilitation in neuromuscular disease. Muscle Nerve 6 (1983) 323-338
14. Siegel I.M., and Weiss L.A. Postural substitution in Duchenne's muscular dystrophy. JAMA 247 (1982) 584
15. Vignos P.J., Wagner M.B., Karlinchak B., and Katirji B. Evaluation of a program for long-term treatment of Duchenne muscular dystrophy. Experience at the University Hospitals of Cleveland. J Bone Joint Surg Am 78 (1996) 1844-1852
16. Vignos Jr. P.J. Rehabilitation in progressive muscular dystrophy. In: Licht S. (Ed). Rehabilitation and medicine (1968), Elizabeth Licht, New Haven, CT
17. Hyde S.A., Fløytrup I., Glent S., et al. A randomized comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular dystrophy. Neuromuscul Disord 10 (2000) 257-263
18. Scott O.M., Hyde S.A., Goddard C., and Dubowitz V. Prevention of deformity in Duchenne muscular dystrophy. A prospective study of passive stretching and splintage. Physiotherapy 67 (1981) 177-180
19. McDonald C.M. Limb contractures in progressive neuromuscular disease and the role of stretching, orthotics, and surgery. Phys Med Rehabil Clin N Am 9 (1998) 187-211
20. Johnson E.W., and Kennedy J.H. Comprehensive management of Duchenne muscular dystrophy. Arch Phys Med Rehabil 52 (1971) 110-114
21. Siegel I.M. Plastic-molded knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy. Arch Phys Med Rehabil 56 (1975) 322
22. Bakker J.P., De Groot I.J., De Jong B.A., Van Tol-De Jager M.A., and Lankhorst G.J. Prescription pattern for orthoses in the Netherlands: use and experience in the ambulatory phase of Duchenne muscular dystrophy. Disabil Rehabil 19 (1997) 318-325
23. Bakker J.P., de Groot I.J., Beckerman H., de Jong B.A., and Lankhorst G.J. The effects of knee-ankle-foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature. Clin Rehabil 14 (2000) 343-359
24. Miller G., and Dunn N. An outline of the management and prognosis of Duchenne muscular dystrophy in Western Australia. Aust Paediatr J 18 (1982) 277-282
25. Rideau Y., Duport G., Delaubier A., Guillou C., Renardel-Irani A., and Bach J.R. Early treatment to preserve quality of locomotion for children with Duchenne muscular dystrophy. Semin Neurol 15 (1995) 9-17
26. Forst J., and Forst R. Lower limb surgery in Duchenne muscular dystrophy. Neuromuscul Disord 9 (1999) 176-181
27. Scher D.M., and Mubarak S.J. Surgical prevention of foot deformity in patients with Duchenne muscular dystrophy. J Pediatr Orthop 22 (2002) 384-391
28. Sussman M. Duchenne muscular dystrophy. J Am Acad Orthop Surg 10 (2002) 138-151
29. Shapiro F. Orthopedic treatment. In: Jones H.R., De Vivo D.C., and Darras B.T. (Eds). Neuromuscular disorders of infancy, childhood, and adolescence: a clinician's approach (2003), Butterworth-Heinemann, Amsterdam/Boston 1259-1263
30. Siegel I.M., Miller J.E., and Ray R.D. Subcutaneous lower limb tenotomy is the treatment of pseudohypertrophic muscular dystrophy: description of technique and presentation of twenty-one cases. J Bone Joint Surg Am 50 (1968) 1437-1443
31. Smith S.E., Green N.E., Cole R.J., Robison J.D., and Fenichel G.M. Prolongation of ambulation in children with Duchenne muscular dystrophy by subcutaneous lower limb tenotomy. J Pediatr Orthop 13 (1993) 336-340
32. Miller G.M., Hsu J.D., Hoffer M.M., and Rentfro R. Posterior tibial tendon transfer: a review of the literature and analysis of 74 procedures. J Pediatr Orthop 2 (1982) 363-370
33. Wagner M.B., Vignos Jr. P.J., Carlozzi C., and Hull A.L. Assessment of hand function in Duchenne muscular dystrophy. Arch Phys Med Rehabil 74 (1993) 801-880
34. Wagner M.B., Vignos Jr. P.J., and Carlozzi C. Duchenne muscular dystrophy: a study of wrist and hand function. Muscle Nerve 12 (1989) 236-244
35. Pellegrini N., Guillon B., Prigent H., et al. Optimization of power wheelchair control for patients with severe Duchenne muscular dystrophy. Neuromuscul Disord 14 (2004) 297-300
36. Eagle M., Bourke J., Bullock R., et al. Managing Duchenne muscular dystrophy-the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord 17 (2007) 470-475
37. Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002. Neuromuscul Disord 12 (2002) 975-983
38. Vignos Jr. P.J., and Watkins M.P. The effect of exercise in muscular dystrophy. JAMA 197 (1966) 843-848
39. Scott O.M., Hyde S.A., Goddard C., Jones R., and Dubowitz V. Effect of exercise in Duchenne muscular dystrophy. Physiotherapy 67 (1981) 174-176
40. de Lateur B.J., and Giaconi R.M. Effect on maximal strength of submaximal exercise in Duchenne muscular dystrophy. Am J Phys Med 58 (1979) 26-36
41. Fowler Jr. W.M. Importance of overwork weakness. Muscle Nerve 7 (1984) 496-499
42. Armstrong R.B., Warren G.L., and Warren J.A. Mechanisms of exercise-induced muscle fibre injury. Sports Med 12 (1991) 184-207
43. Fowler Jr. W.M., and Taylor M. Rehabilitation management of muscular dystrophy and related disorders: I. The role of exercise. Arch Phys Med Rehabil 63 (1982) 319-321
44. Fowler Jr. W.M. Role of physical activity and exercise training in neuromuscular diseases. Am J Phys Med Rehabil 81 suppl (2002) S187-S195
45. McDonald C.M. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 81 suppl (2002) S108-S120
46. Sockolov R., Irwin B., Dressendorfer R.H., and Bernauer E.M. Exercise performance in 6-to-11-year-old boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 58 (1977) 195-201
47. Petrof B.J. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem 179 (1998) 111-123
48. Ansved T. Muscular dystrophies: influence of physical conditioning on the disease evolution. Curr Opin Clin Nutr Metab Care 6 (2003) 435-439
49. Allen D.G. Eccentric muscle damage: mechanisms of early reduction of force. Acta Physiol Scand 171 (2001) 311-319
50. Garrood P., Eagle M., Jardine P.E., Bushby K., and Straub V. Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy. Neuromuscul Disord 18 (2008) 71-73
51. Smith A.D., Koreska J., and Moseley C.F. Progression of scoliosis in Duchenne muscular dystrophy. J Bone Joint Surg Am 71 (1989) 1066-1074
52. Alman B.A., Raza S.N., and Biggar W.D. Steroid treatment and the development of scoliosis in males with Duchenne muscular dystrophy. J Bone Joint Surg Am 86 (2004) 519-524
53. Yilmaz O., Karaduman, and Topaloglu H. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur J Neurol 11 (2004) 541-544
54. Talim B., Malaguti C., Gnudi S., Politano L., and Merlini L. Vertebral compression in Duchenne muscular dystrophy following deflazacort. Neuromuscul Disord 12 (2002) 294-295
55. Bothwell J.E., Gordon K.E., Dooley J.M., Mac Sween J., Cummings E.A., and Salisbury S. Vertebral fractures in boys with Duchenne muscular dystrophy. Clin Pediatr 42 (2003) 353-356
56. Velasco M.V., Colin A.A., Zurakowski D., Darras B.T., and Shapiro F. Posterior spinal fusion for scoliosis in Duchenne muscular dystrophy diminishes the rate of respiratory decline. Spine 32 (2007) 459-465
57. Shapiro F., Sethna N., Colan S., Wohl M.E., and Specht L. Spinal fusion in Duchenne muscular dystrophy: a multidisciplinary approach. Muscle Nerve 15 (1992) 604-614
58. Heller K.D., Wirtz D.C., Siebert C.H., and Forst R. Spinal stabilization in Duchenne muscular dystrophy: principles of treatment and record of 31 operative treated cases. J Pediatr Orthop 10 (2001) 18-24
59. Alman B.A., and Kim H.K.W. Pelvic obliquity after fusion of the spine in Duchenne muscular dystrophy. J Bone Joint Surg Br 81 (1999) 821-824
60. Sengupta D.K., Mehdian S.H., McConnell J.R., Eisenstein S.M., and Webb J.K. Pelvic or lumbar fixation for the surgical management of scoliosis in Duchenne muscular dystrophy. Spine 27 (2002) 2072-2079
61. Quinlivan R., Roper H., Davie M., et al. Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention. Neuromuscul Disord 15 (2005) 72-79
62. Biggar W.D., Bachrach L.K., Henderson R.C., Kalkwarf H., Plotkin H., and Wong B.L. Bone health in Duchenne muscular dystrophy. Neuromuscul Disord 15 (2005) 80-85
63. McDonald D.G.M., Kinali M., Gallagher A.C., et al. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44 (2002) 695-698
64. Phillips M.F., Quinlivan C.M., Edwards R.H., and Calverley P.M. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 164 (2001) 2191-2194
65. Eagle M., Baudouin S.V., Chandler C., Giddings D.R., Bullock R., and Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12 (2002) 926-929
66. Gomez-Merino E., and Bach J.R. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil 81 (2002) 411-415
67. Bach J.R., and Saporito L.R. Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure: a different approach to weaning. Chest 110 (1996) 1566-1571
68. Dohna-Schwake C., Ragette R., Teschler H., Voit T., and Mellies U. Predictors of severe chest infections in pediatric neuromuscular disorders. Neuromuscul Disord 16 (2006) 325-328
69. Bianchi C., and Baiardi P. Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil 87 (2008) 461-467
70. Kang S.W., and Bach J.R. Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease. Am J Phys Med Rehabil 79 (2000) 222-227
71. Daftary A.S., Crisanti M., Kalra M., Wong B., and Amin R. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Pediatrics 117 (2007) e320-e324
72. Gauld L.M., and Boynton A. Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy. Pediatr Pulmonol 39 (2005) 457-460
73. Suarez A.A., Pessolano F.A., Monteiro S.G., et al. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil 81 (2002) 506-511
74. Domenech-Clar R., Lopez-Andreu J.A., Compte-Torrero L., et al. Maximal static respiratory pressures in children and adolescents. Pediatr Pulmonol 35 (2003) 126-132
75. Szeinberg A., Tabachnik E., Rashed N., et al. Cough capacity in patients with muscular dystrophy. Chest 94 (1988) 1232-1235
76. Smith P.E., Calverley P.M., and Edwards R.H. Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis 137 (1988) 884-888
77. Phillips M.F., Smith P.E., Carroll N., Edwards R.H., and Calverley P.M. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med 160 (1999) 198-202
78. Hukins C.A., and Hillman D.R. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Repir Crit Care Med 161 (2000) 166-170
79. Ragette R., Mellies U., Schwake C., Voit T., and Teschler H. Patterns and predictors of sleep disordered breathing in primary myopathies. Thorax 57 (2002) 724-728
80. Khan Y., and Heckmatt J.Z. Obstructive apnoeas in Duchenne muscular dystrophy. Thorax 49 (1994) 157-161
81. Barbe F., Quera-Salva M.A., McCann C., et al. Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy. Eur Respir J 7 (1994) 1403-1408
82. Uliel S., Tauman R., Greenfeld M., and Sivan Y. Normal polysomnographic respiratory values in children and adolescents. Chest 125 (2004) 872-878
83. Toussaint M., Steens M., and Soudon P. Lung function accurately predicts hypercapnia in patients with Duchenne muscular dystrophy. Chest 131 (2007) 368-375
84. Culebras A. Sleep-disordered breathing in neuromuscular disease. Sleep Med Clin 3 (2008) 377-386
85. Finder J.D., Birnkrant D., Carl J., et al. Respiratory care of the patient with Duchenne muscular dystrophy: an official ATS consensus statement. Am J Respir Crit Care Med 170 (2004) 456-465
86. Ward S., Chatwin M., Heather S., and Simonds A.K. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 60 (2005) 1019-1024
87. Bach J.R., and Alba A.S. Management of chronic alveolar hypoventilation by nasal ventilation. Chest 97 (1990) 52-57
88. Mellies U., Ragette R., Schwake C.D., Boehm H., Voit T., and Teschler H. Long-term noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J 22 (2003) 631-636
89. Simonds A.K., Muntoni F., Heather S., and Fielding S. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 53 (1998) 949-952
90. Piastra M., Antonelli M., Caresta E., Chiaretti A., Polidori G., and Conti G. Noninvasive ventilation in childhood acute neuromuscular respiratory failure. Respiration 73 (2006) 791-798
91. Niranjan V., and Bach J.R. Noninvasive management of pediatric neuromuscular respiratory failure. Crit Care Med 26 (1998) 2061-2065
92. Bach J.R., Bianchi C., Vidigal-Lopes M., Turi S., and Felisari G. Lung inflation by glossopharyngeal breathing and air stacking in Duchenne muscular dystrophy. Am J Phys Med Rehabil 86 (2007) 295-300
93. Bach J.R., and Kang S.W. Disorders of ventilation: weakness, stiffness and mobilization. Chest 117 (2000) 301-303
94. 2 retention in patients with neuromuscular disease. Chest 117 (2000) 447-453
95. Tzeng A.C., and Bach J.R. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest 118 (2000) 1390-1396
96. Dohna-Schwake C., Ragette R., Teschler H., Voit T., and Mellies U. IPPB-assisted coughing in neuromuscular disorders. Pediatr Pulmonol 41 (2006) 551-557
97. Miske L.J., Hickey E.M., Kolb S.M., Weiner D.J., and Panitch H.B. Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 125 (2004) 1406-1412
98. Boitano J.L. Management of airway clearance in neuromuscular disease. Respir Care 51 (2006) 913-922
99. Fauroux B., Guillemot N., Aubertin G., et al. Physiological benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. Chest 133 (2008) 161-168
100. Chatwin M., Ross E., Hart N., Nickol A.H., Polkey M.I., and Simonds A.K. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J 21 (2003) 502-508
101. Winck J.C., Goncalves M.R., Lourenco C., Viana P., Almeida J., and Bach J.R. Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest 126 (2004) 774-780
102. Homnick D.N. Mechanical insufflation-exsufflation for airway mucus clearance. Respir Care 52 (2007) 1296-1307
103. Smith P.E., Edwards R.H., and Calverley P.M. Oxygen treatment of sleep hypoxaemia in Duchenne muscular dystrophy. Thorax 44 (1989) 997-1001
104. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 116 (2005) 1569-1573
105. Chenard A.A., Becane H.M., Tertrain F., de Kermadec J.M., and Weiss Y.A. Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul Disord 3 (1993) 201-206
106. de Kermadec J.M., Bécane H.M., Chénard A., Tertrain F., and Weiss Y. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. Am Heart J 127 (1994) 618-623
107. Moriuchi T., Kagawa N., Mukoyama M., and Hizawa K. Autopsy analyses of the muscular dystrophies. Tokushima J Exp Med 40 (1993) 83-93
108. McNally E. New approaches in the therapy of cardiomyopathy in muscular dystrophy. Annu Rev Med 58 (2007) 75-88
109. Giglio V., Pasceri V., Messano L., et al. Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol 42 (2003) 309-316
110. Sasaki K., Sakata K., Kachi E., Hirata S., Ishihara T., and Ishikawa K. Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study. Am Heart J 135 (1998) 937-944
111. Takenaka A., Yokota M., Iwase M., Miyaguchi K., Hayashi H., and Saito H. Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy. Eur Heart J 14 (1993) 669-676
112. Nigro G., Comi L.I., Politano L., and Nigro V. Dilated cardiomyopathy of muscular dystrophy: a multifaceted approach to management. Semin Neurol 15 (1995) 90-92
113. Bushby K., Muntoni F., and Bourke J.P. 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 13 (2003) 166-172
114. Vita G.L., Kirk R., Lochmüller H., Bushby K., and Straub V. Early cardiomyopathy in DMD [abstract GP.13.10]. Neuromuscul Disord 19 (2009) 642
115. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 112 (2005) 1825-1852
116. Saito T., Matsumura T., Miyai I., Nozaki S., and Shinno S. Carvedilol effectiveness for left ventricular-insufficient patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku 41 (2001) 691-694
117. Ishikawa Y., Bach J.R., and Minami R. Cardioprotection for Duchenne's muscular dystrophy. Am Heart J 137 (1999) 895-902
118. Shaddy R.E., Tani L.Y., Gidding S.S., et al. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 18 (1999) 269-274
119. Duboc D., Meune C., Lerebours G., Devaux J.Y., Vaksmann G., and Bécane H.M. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 45 (2005) 855-857
120. Jefferies J.L., Eidem B.W., Belmont J.W., et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112 (2005) 2799-2804
121. Duboc D., Meune C., Pierre B., et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154 (2007) 596-602
122. Meune C., and Duboc D. How should physicians manage patients with Duchenne muscular dystrophy when experts' recommendations are not unanimous?. Dev Med Child Neurol 48 (2006) 863-864
123. Bourke J.P. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Dev Med Child Neurol 48 (2006) 164
124. Yotsukura M., Fujii K., Katayama A., et al. Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy. Am Heart J 136 (1998) 289-296
125. Yotsukura M., Sasaki K., Kachi E., Sasaki A., Ishihara T., and Ishikawa K. Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy. Am J Cardiol 76 (1995) 947-951
126. Lanza G.A., Russo A.D., Giglio V., et al. Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function. Am Heart J 141 (2001) 808-812
127. Corrado G., Lissoni A., Beretta S., et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89 (2002) 838-841
128. In: Kleinman R.E. (Ed). Pediatric nutrition handbook. 6th edn. (2009), Academy of Pediatrics Press, Elk Grove Village, IL
129. Douvillez B., Braillon P., Hodgkinson I., and Berard C. Pain, osteopenia and body composition of 22 patients with Duchenne muscular dystrophy: a descriptive study. Ann Readapt Med Phys 48 (2005) 616-622
130. McCrory M.A., Wright N.C., and Kilmer D.D. Nutritional aspects of neuromuscular disease. Phys Med Rehab Clin North Am 9 (1998) 127
131. Willig T.N., Carlier L., Legrand M., Riviere H., and Navarro J. Nutritional assessment in Duchenne muscular dystrophy. Dev Med Child Neurol 35 (1993) 1074
132. Willig T.N., Bach J.R., Venance V., and Navarro J. Nutritional rehabilitation in neuromuscular disorders. Semin Neurol 15 (1995) 18
133. Jaffe K.M., McDonald C.M., Ingman E., and Haas J. Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case-control study. Arch Phys Med Rehabil 71 (1990) 742-744
134. Logemann J.A. Evaluation and treatment of swallowing disorders. 2nd edn. (1998), ProEd Inc., Austin, TX
135. Bach J.R. Management of patients with neuromuscular disease (2004), Hanley & Belfus, Philadelphia
136. Pane M., Vasta I., Messina S., et al. Feeding problems and weight gain in Duchenne muscular dystrophy. Eur J Paediatr Neurol 10 (2006) 231-236
137. Hanayama K., Liu M., Higuchi Y., et al. Dysphagia in patients with Duchenne muscular dystrophy evaluated with a questionnaire and videofluorography. Disabil Rehabil 30 (2008) 517-522
138. Nozaki S., Umaki Y., Sugishita S., Tatara K., Adachi K., and Shinno S. Videofluorographic assessment of swallowing function in patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku 47 (2007) 407-412
139. Aloysius A., Born P., Kinali M., Davis T., Pane M., and Mercuri E. Swallowing difficulties in Duchenne muscular dystrophy: indications for feeding assessment and outcome of videofluroscopic swallowing studies. Eur J Paediatr Neurol 12 (2008) 239-245
140. Shinonaga C., Fukuda M., Suzuki Y., et al. Evaluation of swallowing function in Duchenne muscular dystrophy. Dev Med Child Neurol 50 (2008) 478-480
141. Zickler R.W., Barbagiovanni J.T., and Swan K.G. A simplified open gastrostomy under local anesthesia. Am Surg 67 (2001) 806-808
142. Gottrand F., Guillonneau I., and Carpentier A. Segmental colonic transit time in Duchenne muscular dystrophy. Arch Dis Child 66 (1991) 1262
143. Tilton A.H., Miller M.D., and Khoshoo V. Nutrition and swallowing in pediatric neuromuscular patients. Semin Pediatr Neurol 5 (1998) 106-115
144. Cyrulnik S.E., Fee R.J., De Vivo D.C., Goldstein E., and Hinton V.J. Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr 150 (2007) 474-478
145. Zebracki K., and Drotar D. Pain and activity limitations in children with Duchenne or Becker muscular dystrophy. Dev Med Child Neurol 50 (2008) 546-552
146. Engel J.M., Kartin D., and Jaffe K.M. Exploring chronic pain in youths with Duchenne muscular dystrophy: a model for pediatric neuromuscular disease. Phys Med Rehabil Clin North Am 16 (2005) 1113-1124 xii.
147. Knopp J.A., Diner B.M., Blitz M., Lyritis G.P., and Rowe B.H. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16 (2005) 1281-1290
148. Armingeat T., Brondino R., Pham T., Legré V., and Lafforgue P. Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study. Osteoporos Int 17 (2006) 1659-1665
149. Hoffman A.J., Jensen M.P., Abresch R.T., and Carter G.T. Chronic pain in persons with neuromuscular disease. Phys Med Rehabil Clin North Am 16 (2005) 1099-1112
150. Jensen M.P., Abresch R.T., Carter G.T., and McDonald C.M. Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil 86 (2005) 1155-1163
151. Ames W.A., Hayes J.A., and Crawford M.W. The role of corticosteroids in Duchenne muscular dystrophy: a review for the anesthetist. Paediatr Anaesth 15 (2005) 3-8
152. Hayes J., Veyckemans F., and Bissonnette B. Duchenne muscular dystrophy: an old anesthesia problem revisited. Pediatr Anesth 18 (2008) 100-106
153. Yemen T.A., and McClain C. Muscular dystrophy, anesthesia and the safety of inhalational agents revisited, again. Paediatr Anaesth 16 (2006) 105-108
154. Shapiro F., Zurakowski D., and Sethna N.F. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for Duchenne muscular dystrophy scoliosis. Spine 32 (2007) 2278-2283
155. Birnkrant D.J., Panitch H.B., Benditt J.O., et al. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 132 (2007) 1977-1986
156. Bach J.R., and Sabharwal S. High pulmonary risk scoliosis surgery: role of noninvasive ventilation and related techniques. J Spinal Disord Tech 18 (2005) 527-530
157. Lumbierres M., Prats E., Farrero E., et al. Noninvasive positive pressure ventilation prevents postoperative pulmonary complications in chronic ventilator users. Respir Med 101 (2007) 62-68